# US 2004/0063222 A1 · Method of assaying pyrrole-containing biological compounds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0063222 A1
- Document ID: US20040063222A1
- Status: Published application
- Kind: A1
- Application number: 10/672,843
- Filed: 2003-09-26
- Published: 2004-04-01
- Earliest claimed: 2000-10-03
- Assignees: Rowett Research Institute
- Inventors: Jeffrey D. Brady; Simon P. Robins
- Web page: https://patentgrep.com/patent/US20040063222A1

## CPC

- C07D 495/04: Ortho-condensed systems
- G01N 33/6887: {from muscle, cartilage or connective tissue}
- Y10S 436/815: Test for named compound or class of compounds
- Y10T 436/145555: Hetero-N
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

This invention relates to a method of assaying pyrrole-containing biological compounds and chemical compositions that can be used in the method. The method involves contacting a biological compound with one of: a) a bound or bindable derivatizing agent which forms a reaction product with the biological compound, followed by exposure to a detectable molecule which forms a complex with the reaction product; or b) a derivatizing agent which forms a reaction product with the biological compound, followed by exposure to a bound binding agent specific to the biological compound in the reaction product; or c) a binding agent specific to the biological compound, followed by exposure to a derivatizing agent which forms a reaction product with the biological compound, and determining the amount of bound biological compound. There is also provided a method of preparing an antigen.

## Claims

### Claim 1

A method of assaying pyrrole-containing biological compounds comprising:
i) contacting a biological compound with one of:
a) an optionally labelled derivatizing agent (bound to or able to bind with a solid support), wherein the derivatizing agent forms a reaction product with the biological compound, followed by exposure to a detectable molecule which forms a complex with the reaction product; or
b) an optionally labelled derivatizing agent not bound to a solid support, wherein the derivatizing agent forms a reaction product with the biological compound, followed by exposure to a binding agent specific to the biological compound in the reaction product, said binding agent being bound to a solid support; or
c) a binding agent bound to a solid support, said binding agent being specific to the biological compound and forming a complex therewith, followed by exposure to an optionally labelled, derivatizing agent which forms a reaction product with the biological compound moiety of said complex, and
ii) determining the amount of bound biological compound by detecting the detectable molecule, or by determining the amount of free or bound binding agent or by measuring the amount of label present; thereby assaying pyrrole containing biological compounds.

### Claim 2 (depends on 1)

The method according to claim 1 comprising:
(a) contacting the biological compound with a derivatizing agent of the following structure in the bound form:
12
wherein R1 is an alkyl group, R2 is an alkyl group, A is a linking group and B is a solid support, and wherein the contact induces formation of a reaction product, and wherein the reaction product comprises the covalent attachment of the biological compound to the derivatizing agent;
(b) contacting the reaction product with a detectable molecule, wherein the contact induces specific binding of the detectable molecule to the reaction product to provide a complex;
(c) detecting the detectable molecule; thereby assaying pyrrole containing biological compounds.

### Claim 3 (depends on 2)

The method according to claim 2, wherein R1 is a straight-chain alkyl group containing 1 to 10 carbon atoms, and R2 is a straight-chain alkyl group containing 1 to 10 carbon atoms.

### Claim 4 (depends on 2)

The method according to claim 2, wherein A is a heteroalkyl group.

### Claim 5 (depends on 2)

The method according to claim 2, wherein the detectable molecule is a first monoclonal antibody.

### Claim 6 (depends on 3)

The method according to claim 3, wherein R1 is a straight-chain alkyl group containing 1 to 5 carbon atoms and R2 is a straight chain alkyl group containing 1 to 5 carbon atoms.

### Claim 7 (depends on 4)

The method according to claim 4, wherein A is a heteroalkyl group comprising at least one nitrogen atom.

### Claim 8 (depends on 5)

The method according to claim 5, wherein the method further comprises contacting the complex with a second monoclonal antibody that specifically binds to the first monoclonal antibody.

### Claim 9 (depends on 6)

The method according to claim 6, wherein the derivatizing agent is of the following structure in bound form:
13

### Claim 10 (depends on 9)

The method according to claim 9, wherein A is a heteroalkyl group containing at least one nitrogen atom, and wherein the detectable molecule is a first monoclonal antibody.

### Claim 11 (depends on 10)

The method according to claim 10, wherein the method further comprises contacting the complex with a second monoclonal antibody that specifically binds to the first monoclonal antibody.

### Claim 12 (depends on 1)

The method according to claim 1 comprising:
a) contacting the biological compound with an optionally labelled derivatizing agent in solution to form a reaction product therewith, followed by exposure to a binding agent bound to a solid support wherein the binding agent is specific to the biological compound in the reaction product; and
b) determining the amount of bound biological compound by determining the amount of labelled dirivatizing agent bound to the solid support; thereby assaying the pyrrole-containing compound.

### Claim 13 (depends on 12)

The method according to claim 12 wherein the derivatizing agent is biotinylated Ehrlich's reagent.

### Claim 14 (depends on 12)

The method according to claim 12 wherein the derivatizing agent is labelled with a radiolabel, fluorescent label or an enzyme label.

### Claim 15 (depends on 12)

The method according to claim 12 wherein the solution containing the reaction product is neutralised prior to contact with the binding agent.

### Claim 16 (depends on 1)

The method according to claim 1 comprising;
a) contacting the biological compound with a derivatizing agent in solution to form a reaction product, wherein the derivatizing agent comprises a first partner of a strong binding pair;
b) contacting the reaction product with a solid support having a second partner of the strong binding pair on its surface, to form a bound complex with the reaction product;
c) contacting the bound complex with a detectable molecule;
d) determining the amount of bound biological compound; thereby assaying the pyrrole-containing biological compound.

### Claim 17 (depends on 16)

The method according to claim 16 wherein the solution containing the reaction product is neutralised prior to contact with the solid support.

### Claim 18 (depends on 16)

The method according to claim 16 wherein the detectable molecule is a monoclonal antibody specific to the biological compound and the amount of bound biological compound is determined by detecting the amount MAb bound to the solid support.

### Claim 19 (depends on 16)

A method as claimed in claim 16 comprising:
a) contacting the biological compound with a derivatizing agent of the following structure in the bound form;
14
wherein R1 is an alkyl group, R2 is an alkyl group, R4 is a heteroalkyl group, X is the first labelling molecule and acts as a first partner of a strong binding pair and Y is the second labelling molecule and acts as a second partner of a strong binding pair on the surface of a solid support, and wherein the contact induces formation of a reaction product, and wherein the reaction product comprises the covalent attachment of the biological compound to the derivatizing agent;
b) contacting the reaction product with a detectable molecule, wherein the contact induces specific binding of the detectable molecule to the reaction product to provide a complex;
c) detecting the detectable molecule; thereby assaying pyrrole containing biological compounds.

### Claim 20 (depends on 19)

The method according to claim 19, wherein R1 is a straight-chain alkyl group containing 1 to 10 carbon atoms, and R2 is a straight-chain alkyl group containing 1 to 10 carbon atoms.

### Claim 21 (depends on 19)

The method according to claim 19, wherein R4 is a straight-chain heteroalkyl group containing 2 to 10 carbon atoms and at least 2 heteroatoms.

### Claim 22 (depends on 19)

The method according to claim 19, wherein Y is a solid support having avidin on its surface.

### Claim 23 (depends on 19)

The method according to claim 19, wherein the detectable molecule is a first monoclonal antibody.

### Claim 24 (depends on 19)

The method according to claim 19, wherein R1 is a straight-chain alkyl group containing 1 to 5 carbon atoms, and R2 is a straight chain alkyl group containing 1 to 5 carbon atoms.

### Claim 25 (depends on 18)

The method according to claim 18, wherein the method further comprises contacting the complex with a second monoclonal antibody that specifically binds to the first monoclonal antibody.

### Claim 26 (depends on 25)

The method according to claim 25, wherein the derivatizing agent, in bound form, is of the following structure:
15
wherein R1 is a straight-chain alkyl group containing 1 to 5 carbon atoms, R2 is a straight-chain alkyl group containing 1 to 5 carbon atoms, R4 is a straight-chain heteroalkyl group containing 2 to 10 carbon atoms and at least 2 heteroatoms, and Y is a solid support having avidin or streptavidin on its surface.

### Claim 27 (depends on 26)

The method according to claim 26, wherein R1 is —CH3, R2 is —CH2CH2— and R4 is —NH(CH2)5NH— or —NH (CH2)2SS (CH2)2NHC (O) (CH2)5NH—.

### Claim 28 (depends on 27)

The method according to claim 27, wherein R4 is —NH (CH2)5NH—.
